Haemonetics Corp. (HAE) Misses Q2 EPS Views; Affirms Outlook
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $90.80 +0.46%
Financial Fact:
Other income/(expense), net: -1.96M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Other income/(expense), net: -1.96M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Haemonetics Corp. (NYSE: HAE) reported Q2 EPS of $0.65, $0.13 worse than the analyst estimate of $0.78. Revenue for the quarter came in at $170.6 million versus the consensus estimate of $170.4 million.
Affirms outlook.
Affirms outlook.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
- Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
